
Global Lurasidone Hydrochloride Generics Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031
Description
Summary
According to APO Research, The global Lurasidone Hydrochloride Generics market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Lurasidone Hydrochloride Generics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Lurasidone Hydrochloride Generics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Lurasidone Hydrochloride Generics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Lurasidone Hydrochloride Generics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Lurasidone Hydrochloride Generics include Chia Tai Tianqing Pharmaceutical, Zhejiang Huahai Pharmaceutical, YaoPharma, Yangtze River Pharmaceutical, SJZ No.4 Pharmaceutical, Shandong Jewim Pharmaceutical, Qilu Pharmaceutical, Hansoh Pharma and Hisun Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Lurasidone Hydrochloride Generics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Lurasidone Hydrochloride Generics, also provides the sales of main regions and countries. Of the upcoming market potential for Lurasidone Hydrochloride Generics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Lurasidone Hydrochloride Generics sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Lurasidone Hydrochloride Generics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Lurasidone Hydrochloride Generics sales, projected growth trends, production technology, application and end-user industry.
Lurasidone Hydrochloride Generics Segment by Company
Chia Tai Tianqing Pharmaceutical
Zhejiang Huahai Pharmaceutical
YaoPharma
Yangtze River Pharmaceutical
SJZ No.4 Pharmaceutical
Shandong Jewim Pharmaceutical
Qilu Pharmaceutical
Hansoh Pharma
Hisun Pharmaceuticals
Cisen Pharmaceutical
Changzhou Pharmaceutical Factory
Zydus
Sun Pharmaceuticals
MSN
Lupin
Dr. Reddy's Laboratories
Amneal
Alkem
Alembic pharmaceuticals
Accord Healthcare
Lurasidone Hydrochloride Generics Segment by Type
20mg per Tablet
40mg per Tablet
60mg per Tablet
80mg per Tablet
120mg per Tablet
Lurasidone Hydrochloride Generics Segment by Application
Schizophrenia
Bipolar Depression
Lurasidone Hydrochloride Generics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lurasidone Hydrochloride Generics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lurasidone Hydrochloride Generics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lurasidone Hydrochloride Generics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Lurasidone Hydrochloride Generics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lurasidone Hydrochloride Generics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Lurasidone Hydrochloride Generics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Lurasidone Hydrochloride Generics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, The global Lurasidone Hydrochloride Generics market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Lurasidone Hydrochloride Generics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Lurasidone Hydrochloride Generics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Lurasidone Hydrochloride Generics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Lurasidone Hydrochloride Generics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Lurasidone Hydrochloride Generics include Chia Tai Tianqing Pharmaceutical, Zhejiang Huahai Pharmaceutical, YaoPharma, Yangtze River Pharmaceutical, SJZ No.4 Pharmaceutical, Shandong Jewim Pharmaceutical, Qilu Pharmaceutical, Hansoh Pharma and Hisun Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Lurasidone Hydrochloride Generics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Lurasidone Hydrochloride Generics, also provides the sales of main regions and countries. Of the upcoming market potential for Lurasidone Hydrochloride Generics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Lurasidone Hydrochloride Generics sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Lurasidone Hydrochloride Generics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Lurasidone Hydrochloride Generics sales, projected growth trends, production technology, application and end-user industry.
Lurasidone Hydrochloride Generics Segment by Company
Chia Tai Tianqing Pharmaceutical
Zhejiang Huahai Pharmaceutical
YaoPharma
Yangtze River Pharmaceutical
SJZ No.4 Pharmaceutical
Shandong Jewim Pharmaceutical
Qilu Pharmaceutical
Hansoh Pharma
Hisun Pharmaceuticals
Cisen Pharmaceutical
Changzhou Pharmaceutical Factory
Zydus
Sun Pharmaceuticals
MSN
Lupin
Dr. Reddy's Laboratories
Amneal
Alkem
Alembic pharmaceuticals
Accord Healthcare
Lurasidone Hydrochloride Generics Segment by Type
20mg per Tablet
40mg per Tablet
60mg per Tablet
80mg per Tablet
120mg per Tablet
Lurasidone Hydrochloride Generics Segment by Application
Schizophrenia
Bipolar Depression
Lurasidone Hydrochloride Generics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lurasidone Hydrochloride Generics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lurasidone Hydrochloride Generics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lurasidone Hydrochloride Generics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Lurasidone Hydrochloride Generics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lurasidone Hydrochloride Generics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Lurasidone Hydrochloride Generics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Lurasidone Hydrochloride Generics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
192 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Lurasidone Hydrochloride Generics Market Size, 2020 VS 2024 VS 2031
- 1.3 Global Lurasidone Hydrochloride Generics Market Size Estimates and Forecasts (2020-2031)
- 1.4 Global Lurasidone Hydrochloride Generics Sales Estimates and Forecasts (2020-2031)
- 1.5 Global Lurasidone Hydrochloride Generics Market Average Price (2020-2031)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 2 Global Lurasidone Hydrochloride Generics Market Dynamics
- 2.1 Lurasidone Hydrochloride Generics Industry Trends
- 2.2 Lurasidone Hydrochloride Generics Industry Drivers
- 2.3 Lurasidone Hydrochloride Generics Industry Opportunities and Challenges
- 2.4 Lurasidone Hydrochloride Generics Industry Restraints
- 3 Lurasidone Hydrochloride Generics Market by Manufacturers
- 3.1 Global Lurasidone Hydrochloride Generics Revenue by Manufacturers (2020-2025)
- 3.2 Global Lurasidone Hydrochloride Generics Sales by Manufacturers (2020-2025)
- 3.3 Global Lurasidone Hydrochloride Generics Average Sales Price by Manufacturers (2020-2025)
- 3.4 Global Lurasidone Hydrochloride Generics Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
- 3.5 Global Lurasidone Hydrochloride Generics Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Lurasidone Hydrochloride Generics Manufacturers, Product Type & Application
- 3.7 Global Lurasidone Hydrochloride Generics Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Lurasidone Hydrochloride Generics Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Lurasidone Hydrochloride Generics Players Market Share by Revenue in 2024
- 3.8.3 2024 Lurasidone Hydrochloride Generics Tier 1, Tier 2, and Tier 3
- 4 Lurasidone Hydrochloride Generics Market by Type
- 4.1 Lurasidone Hydrochloride Generics Type Introduction
- 4.1.1 20mg per Tablet
- 4.1.2 40mg per Tablet
- 4.1.3 60mg per Tablet
- 4.1.4 80mg per Tablet
- 4.1.5 120mg per Tablet
- 4.2 Global Lurasidone Hydrochloride Generics Sales by Type
- 4.2.1 Global Lurasidone Hydrochloride Generics Sales by Type (2020 VS 2024 VS 2031)
- 4.2.2 Global Lurasidone Hydrochloride Generics Sales by Type (2020-2031)
- 4.2.3 Global Lurasidone Hydrochloride Generics Sales Market Share by Type (2020-2031)
- 4.3 Global Lurasidone Hydrochloride Generics Revenue by Type
- 4.3.1 Global Lurasidone Hydrochloride Generics Revenue by Type (2020 VS 2024 VS 2031)
- 4.3.2 Global Lurasidone Hydrochloride Generics Revenue by Type (2020-2031)
- 4.3.3 Global Lurasidone Hydrochloride Generics Revenue Market Share by Type (2020-2031)
- 5 Lurasidone Hydrochloride Generics Market by Application
- 5.1 Lurasidone Hydrochloride Generics Application Introduction
- 5.1.1 Schizophrenia
- 5.1.2 Bipolar Depression
- 5.2 Global Lurasidone Hydrochloride Generics Sales by Application
- 5.2.1 Global Lurasidone Hydrochloride Generics Sales by Application (2020 VS 2024 VS 2031)
- 5.2.2 Global Lurasidone Hydrochloride Generics Sales by Application (2020-2031)
- 5.2.3 Global Lurasidone Hydrochloride Generics Sales Market Share by Application (2020-2031)
- 5.3 Global Lurasidone Hydrochloride Generics Revenue by Application
- 5.3.1 Global Lurasidone Hydrochloride Generics Revenue by Application (2020 VS 2024 VS 2031)
- 5.3.2 Global Lurasidone Hydrochloride Generics Revenue by Application (2020-2031)
- 5.3.3 Global Lurasidone Hydrochloride Generics Revenue Market Share by Application (2020-2031)
- 6 Global Lurasidone Hydrochloride Generics Sales by Region
- 6.1 Global Lurasidone Hydrochloride Generics Sales by Region: 2020 VS 2024 VS 2031
- 6.2 Global Lurasidone Hydrochloride Generics Sales by Region (2020-2031)
- 6.2.1 Global Lurasidone Hydrochloride Generics Sales by Region (2020-2025)
- 6.2.2 Global Lurasidone Hydrochloride Generics Sales Forecasted by Region (2025-2030)
- 6.3 North America
- 6.3.1 North America Lurasidone Hydrochloride Generics Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.3.2 North America Lurasidone Hydrochloride Generics Sales by Country (2020-2031)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Lurasidone Hydrochloride Generics Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.4.2 Europe Lurasidone Hydrochloride Generics Sales by Country (2020-2031)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Lurasidone Hydrochloride Generics Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.5.2 Asia Pacific Lurasidone Hydrochloride Generics Sales by Country (2020-2031)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Lurasidone Hydrochloride Generics Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.6.2 South America, Middle East and Africa Lurasidone Hydrochloride Generics Sales by Country (2020-2031)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
- 7 Global Lurasidone Hydrochloride Generics Revenue by Region
- 7.1 Global Lurasidone Hydrochloride Generics Revenue by Region
- 7.1.1 Global Lurasidone Hydrochloride Generics Revenue by Region: 2020 VS 2024 VS 2031
- 7.1.2 Global Lurasidone Hydrochloride Generics Revenue by Region (2020-2025)
- 7.1.3 Global Lurasidone Hydrochloride Generics Revenue by Region (2026-2031)
- 7.1.4 Global Lurasidone Hydrochloride Generics Revenue Market Share by Region (2020-2031)
- 7.2 North America
- 7.2.1 North America Lurasidone Hydrochloride Generics Revenue (2020-2031)
- 7.2.2 North America Lurasidone Hydrochloride Generics Revenue Share by Country: 2020 VS 2024 VS 2031
- 7.3 Europe
- 7.3.1 Europe Lurasidone Hydrochloride Generics Revenue (2020-2031)
- 7.3.2 Europe Lurasidone Hydrochloride Generics Revenue Share by Country: 2020 VS 2024 VS 2031
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Lurasidone Hydrochloride Generics Revenue (2020-2031)
- 7.4.2 Asia-Pacific Lurasidone Hydrochloride Generics Revenue Share by Country: 2020 VS 2024 VS 2031
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Lurasidone Hydrochloride Generics Revenue (2020-2031)
- 7.5.2 South America, Middle East and Africa Lurasidone Hydrochloride Generics Revenue Share by Country: 2020 VS 2024 VS 2031
- 8 Company Profiles
- 8.1 Chia Tai Tianqing Pharmaceutical
- 8.1.1 Chia Tai Tianqing Pharmaceutical Comapny Information
- 8.1.2 Chia Tai Tianqing Pharmaceutical Business Overview
- 8.1.3 Chia Tai Tianqing Pharmaceutical Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.1.4 Chia Tai Tianqing Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio
- 8.1.5 Chia Tai Tianqing Pharmaceutical Recent Developments
- 8.2 Zhejiang Huahai Pharmaceutical
- 8.2.1 Zhejiang Huahai Pharmaceutical Comapny Information
- 8.2.2 Zhejiang Huahai Pharmaceutical Business Overview
- 8.2.3 Zhejiang Huahai Pharmaceutical Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.2.4 Zhejiang Huahai Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio
- 8.2.5 Zhejiang Huahai Pharmaceutical Recent Developments
- 8.3 YaoPharma
- 8.3.1 YaoPharma Comapny Information
- 8.3.2 YaoPharma Business Overview
- 8.3.3 YaoPharma Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.3.4 YaoPharma Lurasidone Hydrochloride Generics Product Portfolio
- 8.3.5 YaoPharma Recent Developments
- 8.4 Yangtze River Pharmaceutical
- 8.4.1 Yangtze River Pharmaceutical Comapny Information
- 8.4.2 Yangtze River Pharmaceutical Business Overview
- 8.4.3 Yangtze River Pharmaceutical Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.4.4 Yangtze River Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio
- 8.4.5 Yangtze River Pharmaceutical Recent Developments
- 8.5 SJZ No.4 Pharmaceutical
- 8.5.1 SJZ No.4 Pharmaceutical Comapny Information
- 8.5.2 SJZ No.4 Pharmaceutical Business Overview
- 8.5.3 SJZ No.4 Pharmaceutical Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.5.4 SJZ No.4 Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio
- 8.5.5 SJZ No.4 Pharmaceutical Recent Developments
- 8.6 Shandong Jewim Pharmaceutical
- 8.6.1 Shandong Jewim Pharmaceutical Comapny Information
- 8.6.2 Shandong Jewim Pharmaceutical Business Overview
- 8.6.3 Shandong Jewim Pharmaceutical Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.6.4 Shandong Jewim Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio
- 8.6.5 Shandong Jewim Pharmaceutical Recent Developments
- 8.7 Qilu Pharmaceutical
- 8.7.1 Qilu Pharmaceutical Comapny Information
- 8.7.2 Qilu Pharmaceutical Business Overview
- 8.7.3 Qilu Pharmaceutical Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.7.4 Qilu Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio
- 8.7.5 Qilu Pharmaceutical Recent Developments
- 8.8 Hansoh Pharma
- 8.8.1 Hansoh Pharma Comapny Information
- 8.8.2 Hansoh Pharma Business Overview
- 8.8.3 Hansoh Pharma Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.8.4 Hansoh Pharma Lurasidone Hydrochloride Generics Product Portfolio
- 8.8.5 Hansoh Pharma Recent Developments
- 8.9 Hisun Pharmaceuticals
- 8.9.1 Hisun Pharmaceuticals Comapny Information
- 8.9.2 Hisun Pharmaceuticals Business Overview
- 8.9.3 Hisun Pharmaceuticals Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.9.4 Hisun Pharmaceuticals Lurasidone Hydrochloride Generics Product Portfolio
- 8.9.5 Hisun Pharmaceuticals Recent Developments
- 8.10 Cisen Pharmaceutical
- 8.10.1 Cisen Pharmaceutical Comapny Information
- 8.10.2 Cisen Pharmaceutical Business Overview
- 8.10.3 Cisen Pharmaceutical Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.10.4 Cisen Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio
- 8.10.5 Cisen Pharmaceutical Recent Developments
- 8.11 Changzhou Pharmaceutical Factory
- 8.11.1 Changzhou Pharmaceutical Factory Comapny Information
- 8.11.2 Changzhou Pharmaceutical Factory Business Overview
- 8.11.3 Changzhou Pharmaceutical Factory Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.11.4 Changzhou Pharmaceutical Factory Lurasidone Hydrochloride Generics Product Portfolio
- 8.11.5 Changzhou Pharmaceutical Factory Recent Developments
- 8.12 Zydus
- 8.12.1 Zydus Comapny Information
- 8.12.2 Zydus Business Overview
- 8.12.3 Zydus Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.12.4 Zydus Lurasidone Hydrochloride Generics Product Portfolio
- 8.12.5 Zydus Recent Developments
- 8.13 Sun Pharmaceuticals
- 8.13.1 Sun Pharmaceuticals Comapny Information
- 8.13.2 Sun Pharmaceuticals Business Overview
- 8.13.3 Sun Pharmaceuticals Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.13.4 Sun Pharmaceuticals Lurasidone Hydrochloride Generics Product Portfolio
- 8.13.5 Sun Pharmaceuticals Recent Developments
- 8.14 MSN
- 8.14.1 MSN Comapny Information
- 8.14.2 MSN Business Overview
- 8.14.3 MSN Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.14.4 MSN Lurasidone Hydrochloride Generics Product Portfolio
- 8.14.5 MSN Recent Developments
- 8.15 Lupin
- 8.15.1 Lupin Comapny Information
- 8.15.2 Lupin Business Overview
- 8.15.3 Lupin Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.15.4 Lupin Lurasidone Hydrochloride Generics Product Portfolio
- 8.15.5 Lupin Recent Developments
- 8.16 Dr. Reddy's Laboratories
- 8.16.1 Dr. Reddy's Laboratories Comapny Information
- 8.16.2 Dr. Reddy's Laboratories Business Overview
- 8.16.3 Dr. Reddy's Laboratories Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.16.4 Dr. Reddy's Laboratories Lurasidone Hydrochloride Generics Product Portfolio
- 8.16.5 Dr. Reddy's Laboratories Recent Developments
- 8.17 Amneal
- 8.17.1 Amneal Comapny Information
- 8.17.2 Amneal Business Overview
- 8.17.3 Amneal Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.17.4 Amneal Lurasidone Hydrochloride Generics Product Portfolio
- 8.17.5 Amneal Recent Developments
- 8.18 Alkem
- 8.18.1 Alkem Comapny Information
- 8.18.2 Alkem Business Overview
- 8.18.3 Alkem Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.18.4 Alkem Lurasidone Hydrochloride Generics Product Portfolio
- 8.18.5 Alkem Recent Developments
- 8.19 Alembic pharmaceuticals
- 8.19.1 Alembic pharmaceuticals Comapny Information
- 8.19.2 Alembic pharmaceuticals Business Overview
- 8.19.3 Alembic pharmaceuticals Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.19.4 Alembic pharmaceuticals Lurasidone Hydrochloride Generics Product Portfolio
- 8.19.5 Alembic pharmaceuticals Recent Developments
- 8.20 Accord Healthcare
- 8.20.1 Accord Healthcare Comapny Information
- 8.20.2 Accord Healthcare Business Overview
- 8.20.3 Accord Healthcare Lurasidone Hydrochloride Generics Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.20.4 Accord Healthcare Lurasidone Hydrochloride Generics Product Portfolio
- 8.20.5 Accord Healthcare Recent Developments
- 9 Value Chain and Sales Channels Analysis
- 9.1 Lurasidone Hydrochloride Generics Value Chain Analysis
- 9.1.1 Lurasidone Hydrochloride Generics Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Lurasidone Hydrochloride Generics Production Mode & Process
- 9.2 Lurasidone Hydrochloride Generics Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Lurasidone Hydrochloride Generics Distributors
- 9.2.3 Lurasidone Hydrochloride Generics Customers
- 10 Concluding Insights
- 11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.